Roche Holding AG, Bristol-Myers Squibb Co and PhRMA at JPMorgan Healthcare Conference - Panel Session Transcript

Jan 15, 2020 / 01:00AM GMT
Richard Vosser - JP Morgan Chase & Co, Research Division - Senior Analyst

Welcome to the Roche presentation at the JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst with JPMorgan, and it's my great pleasure to introduce from Roche, Bill Anderson, the CEO of Roche Pharmaceuticals.

Before I hand over to Bill, I'd just point out that the breakout session after his presentation is in the Borgia Room, which is at the back of the hall. Bill, welcome.

William N. Anderson - Roche Holding AG - CEO of Roche Pharmaceuticals

Thanks, Richard. Welcome, everyone. Thanks for being here. I have the duty now to tell you everything that's going on in Roche in 25 minutes. I won't try that.

I do want to -- I want to focus really on 3 themes, really, one is the strategy, which I think everyone is interested in and how we pull this all together, the many diverse parts of what Roche brings in pharmaceuticals, in diagnostics and in the insights businesses. But also I'm going to talk a little bit about culture and the cultural

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot